University of Phoenix Releases White Paper on Trauma-Informed Education
The University of Phoenix's latest white paper outlines trauma-informed teaching strategies that enhance student well-being and course completion for adult learners.
KEYTRUDA and LENVIMA Show Promising Five-Year Survival in Endometrial Cancer
Long-term study reveals KEYTRUDA and LENVIMA improve survival rates for advanced endometrial carcinoma compared to chemotherapy alone.
Dr. Duygu Isil Gencer Highlights Menopause Health Strategies
Dr. Duygu Isil Gencer of Medipol Mega University Hospital discusses menopause risk management through balanced nutrition and healthy living.
Genmab’s Rina-S Shows Promise in Treating Advanced Endometrial Cancer
Genmab's Rinatabart Sesutecan (Rina-S®) demonstrates significant anti-tumor activity in advanced endometrial cancer patients, according to new trial data.
Deciphera Reveals Long-Term Efficacy Data for ROMVIMZA™ at ESMO 2025
Deciphera Pharmaceuticals shares promising two-year results for ROMVIMZA™ in treating Tenosynovial Giant Cell Tumor at ESMO 2025 in Berlin.
Exelixis Presents CABOMETYX® Findings for Lung and Thymic NETs
Exelixis reveals significant results from CABINET trial on CABOMETYX® for advanced lung and thymic neuroendocrine tumors at ESMO 2025.
Salubris Biotherapeutics Reveals Promising JK06 Data at ESMO 2025
Salubris Biotherapeutics presents encouraging data for JK06, a targeted cancer therapy, showing efficacy in advanced lung and breast cancers at ESMO 2025.
Alliant Insurance Services Enhances Texas Operations with Key Acquisitions
Alliant Insurance Services reinforces its Texas presence by acquiring McAfee Insurance Agency and hiring industry veterans to boost cross-border transportation expertise.
U-Haul Provides 30 Days Free Storage for Typhoon Victims in Alaska
U-Haul offers free storage solutions for Alaskan residents impacted by Typhoon Halong, aiding recovery efforts for displaced families across the state.
Light & Wonder Updates on Legal Proceedings with Aristocrat in NV
Light & Wonder shares recent developments in its legal battle with Aristocrat, as Nevada court grants renewed discovery request for game models.
Investors of MoonLake Immunotherapeutics Face Losses Amid Fraud Inquiry
Investors in MoonLake Immunotherapeutics confront potential losses as legal investigations into securities fraud unfold following disappointing drug trial results.
Kolibri Global Energy Inc. Updates Shareholders on Special Meeting
Kolibri Global Energy Inc. informs shareholders about changes to the management circular ahead of a key vote on share issuance limits, urging a stance against the proposal.
Investors Urged to Act Amid Securities Fraud Probe into MoonLake Immunotherapeutics
A securities fraud investigation is underway involving MoonLake Immunotherapeutics, prompting affected investors to reach out for potential claims recovery.
Investors Target MoonLake Immunotherapeutics in Securities Fraud Probe
The Law Offices of Frank R. Cruz is investigating potential securities fraud involving MoonLake Immunotherapeutics after a significant stock drop.
Rosen Law Firm Launches Investigation into Brunello Cucinelli’s Practices
Rosen Law Firm is probing potential securities claims against Brunello Cucinelli S.p.A. amid allegations of misleading business information.
C3.ai Faces Class Action Lawsuit: Deadline Approaches for Investors
Investors with losses over $100,000 in C3.ai have until October 21 to file claims in a pending class action lawsuit led by Kahn Swick & Foti, LLC.
Kahn Swick & Foti Urges Snap Investors to Act Before Deadline
Investors with losses over $100K in Snap Inc. have until Oct 20, 2025, to file claims in a class action lawsuit, according to Kahn Swick & Foti, LLC.